NCT02211664View on ClinicalTrials.gov

Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Stenotic Disease With the Biotronik Passeo-18 Lux Drug Releasing Balloon and the Biotronik Pulsar-18 Stent (Comparing With 4EVER Trial Results)

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

March 31, 2018

Conditions

Peripheral Vascular Disease

Interventions

DEVICE

Passeo-18 balloon

DEVICE

Passeo-18 Lux drug releasing balloon

DEVICE

Pulsar-18 stent

Trial Locations (5)

2650

University Hospital Antwerp, Edegem

2820

Imelda Hospital, Bonheiden

3300

RZ Heilig Hart Hospital, Tienen

9200

AZ Sint-Blasius, Dendermonde

9300

OLV Hospital, Aalst

All Listed Sponsors

lead

Flanders Medical Research Program

NETWORK

NCT02211664 - Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Stenotic Disease With the Biotronik Passeo-18 Lux Drug Releasing Balloon and the Biotronik Pulsar-18 Stent (Comparing With 4EVER Trial Results) | Biotech Hunter | Biotech Hunter